“Glucan (Beta-1, 3-D) has been shown to enhance macrophage production dramatically, and to increase nonspecific host resistance to a variety of bacterial, fungal, and parasitic
infections.”
M. L. Patchen, Ph.D.
Department of Experimental Hematology and Radiation Sciences
Armed Forces Radiobiology Institute
_____________
"Beta-1, 3-D Glucan is a potent macrophage stimulant and is beneficial in the therapy of experimental bacterial, viral and fungal
diseases."
William Browder, M.D.
Department of Surgery
Tulane University School of Medicine
_____________
“A cascade of interactions and reactions initiated by the macrophage regulatory factors can be envisioned to occur and to eventuate in conversion of the glucan treated host to an arsenal of defense.”
Joyce K. Czop, M.D.
Department of Rheumatology and Immunology
Harvard Medical School
_____________
“Glucan was found to be an effective drug in inducing macrophage-mediated destruction in malignant lesions in animals and humans.”
P. Mansell, M.D.
McGill University Cancer Research Center
Victoria Hospital, Montreal, Canada
_____________
“The broad spectrum of immunopharmacological activities of glucan includes not only the modification of certain bacterial, fungal, viral, and parasitic infections, but also inhibition of tumor growth.”
Nicholas DiLuzio, Ph. D.
Department of Physiology
Tulane University School of Medicine
